Literature DB >> 31431368

Predicting the tumor response to chemoradiotherapy for rectal cancer: Model development and external validation using MRI radiomics.

Philippe Bulens1, Alice Couwenberg2, Martijn Intven2, Annelies Debucquoy1, Vincent Vandecaveye3, Eric Van Cutsem4, André D'Hoore5, Albert Wolthuis5, Pritam Mukherjee6, Olivier Gevaert6, Karin Haustermans7.   

Abstract

BACKGROUND: In well-responding patients to chemoradiotherapy for locally advanced rectal cancer (LARC), a watch-and-wait strategy can be considered. To implement organ-sparing strategies, accurate patient selection is needed. We investigate the use of MRI-based radiomics models to predict tumor response to improve patient selection.
MATERIALS AND METHODS: Models were developed in a cohort of 70 patients and validated in an external cohort of 55 patients. Patients received chemoradiation followed by surgery and underwent T2-weighted and diffusion-weighted MRI (DW-MRI) before and after chemoradiation. The outcome measure was (near-)complete pathological tumor response (ypT0-1N0). Tumor segmentation was done on T2-images and transferred to b800-images and ADC maps, after which quantitative and four semantic features were extracted. We combined features using principal component analysis and built models using LASSO regression analysis. The best models based on precision and performance were selected for validation.
RESULTS: 21/70 patients (30%) achieved ypT0-1N0 in the development cohort versus 13/55 patients (24%) in the validation cohort. Three models (t2_dwi_pre_post, semantic_dwi_adc_pre, semantic_dwi_post) were identified with an area-under-the-curve (AUC) of 0.83 (95% CI 0.70-0.95), 0.86 (95% CI 0.75-0.98) and 0.84 (95% CI 0.75-0.94) respectively. Two models (t2_dwi_pre_post, semantic_dwi_post) validated well in the external cohort with AUCs of 0.83 (95% CI 0.70-0.95) and 0.86 (95% CI 0.76-0.97). These models however did not outperform a previously established four-feature semantic model.
CONCLUSION: Prediction models based on MRI radiomics non-invasively predict tumor response after chemoradiation for rectal cancer and can be used as an additional tool to identify patients eligible for an organ-preserving treatment.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Magnetic resonance imaging; Radiomics; Rectal cancer; Response prediction

Mesh:

Year:  2019        PMID: 31431368      PMCID: PMC6997038          DOI: 10.1016/j.radonc.2019.07.033

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  37 in total

Review 1.  A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis.

Authors:  Fahima Dossa; Tyler R Chesney; Sergio A Acuna; Nancy N Baxter
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-05-04

2.  Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

Authors:  Yanfen Cui; Xiaotang Yang; Zhongqiang Shi; Zhao Yang; Xiaosong Du; Zhikai Zhao; Xintao Cheng
Journal:  Eur Radiol       Date:  2018-08-20       Impact factor: 5.315

Review 3.  The role of diffusion-weighted MRI and (18)F-FDG PET/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: a systematic review.

Authors:  Ines Joye; Christophe M Deroose; Vincent Vandecaveye; Karin Haustermans
Journal:  Radiother Oncol       Date:  2014-11       Impact factor: 6.280

4.  Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer.

Authors:  D A M Sloothaak; D E Geijsen; N J van Leersum; C J A Punt; C J Buskens; W A Bemelman; P J Tanis
Journal:  Br J Surg       Date:  2013-03-27       Impact factor: 6.939

5.  MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study.

Authors:  Doenja M J Lambregts; Sheng-Xiang Rao; Sander Sassen; Milou H Martens; Luc A Heijnen; Jeroen Buijsen; Meindert Sosef; Geerard L Beets; Roy A Vliegen; Regina G H Beets-Tan
Journal:  Ann Surg       Date:  2015-12       Impact factor: 12.969

6.  Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features.

Authors:  Olivier Gevaert; Lex A Mitchell; Achal S Achrol; Jiajing Xu; Sebastian Echegaray; Gary K Steinberg; Samuel H Cheshier; Sandy Napel; Greg Zaharchuk; Sylvia K Plevritis
Journal:  Radiology       Date:  2014-05-12       Impact factor: 11.105

7.  Core samples for radiomics features that are insensitive to tumor segmentation: method and pilot study using CT images of hepatocellular carcinoma.

Authors:  Sebastian Echegaray; Olivier Gevaert; Rajesh Shah; Aya Kamaya; John Louie; Nishita Kothary; Sandy Napel
Journal:  J Med Imaging (Bellingham)       Date:  2015-11-18

8.  Radiomic features of pretreatment MRI could identify T stage in patients with rectal cancer: Preliminary findings.

Authors:  Yiqun Sun; Panpan Hu; Jiazhou Wang; Lijun Shen; Fan Xia; Gan Qing; Weigang Hu; Zhen Zhang; Chao Xin; Weijun Peng; Tong Tong; Yajia Gu
Journal:  J Magn Reson Imaging       Date:  2018-02-13       Impact factor: 4.813

9.  Predictive radiogenomics modeling of EGFR mutation status in lung cancer.

Authors:  Olivier Gevaert; Sebastian Echegaray; Amanda Khuong; Chuong D Hoang; Joseph B Shrager; Kirstin C Jensen; Gerald J Berry; H Henry Guo; Charles Lau; Sylvia K Plevritis; Daniel L Rubin; Sandy Napel; Ann N Leung
Journal:  Sci Rep       Date:  2017-01-31       Impact factor: 4.379

10.  Magnetic Resonance Imaging Evaluation in Neoadjuvant Therapy of Locally Advanced Rectal Cancer: A Systematic Review.

Authors:  Roberta Fusco; Mario Petrillo; Vincenza Granata; Salvatore Filice; Mario Sansone; Orlando Catalano; Antonella Petrillo
Journal:  Radiol Oncol       Date:  2017-08-16       Impact factor: 2.991

View more
  20 in total

1.  Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models.

Authors:  Iram Shahzadi; Alex Zwanenburg; Annika Lattermann; Annett Linge; Christian Baldus; Jan C Peeken; Stephanie E Combs; Markus Diefenhardt; Claus Rödel; Simon Kirste; Anca-Ligia Grosu; Michael Baumann; Mechthild Krause; Esther G C Troost; Steffen Löck
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

2.  Combined artificial intelligence and radiologist model for predicting rectal cancer treatment response from magnetic resonance imaging: an external validation study.

Authors:  Natally Horvat; Harini Veeraraghavan; Caio S R Nahas; David D B Bates; Felipe R Ferreira; Junting Zheng; Marinela Capanu; James L Fuqua; Maria Clara Fernandes; Ramon E Sosa; Vetri Sudar Jayaprakasam; Giovanni G Cerri; Sergio C Nahas; Iva Petkovska
Journal:  Abdom Radiol (NY)       Date:  2022-06-16

Review 3.  Rectal MRI radiomics for predicting pathological complete response: Where we are.

Authors:  Joao Miranda; Gary Xia Vern Tan; Maria Clara Fernandes; Onur Yildirim; John A Sims; Jose de Arimateia Batista Araujo-Filho; Felipe Augusto de M Machado; Antonildes N Assuncao-Jr; Cesar Higa Nomura; Natally Horvat
Journal:  Clin Imaging       Date:  2021-11-16       Impact factor: 2.420

4.  Development of a Joint Prediction Model Based on Both the Radiomics and Clinical Factors for Predicting the Tumor Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer.

Authors:  Yang Liu; Feng-Jiao Zhang; Xi-Xi Zhao; Yuan Yang; Chun-Yi Liang; Li-Li Feng; Xiang-Bo Wan; Yi Ding; Yao-Wei Zhang
Journal:  Cancer Manag Res       Date:  2021-04-13       Impact factor: 3.989

5.  Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development.

Authors:  Giuditta Chiloiro; Davide Cusumano; Paola de Franco; Jacopo Lenkowicz; Luca Boldrini; Davide Carano; Brunella Barbaro; Barbara Corvari; Nicola Dinapoli; Martina Giraffa; Elisa Meldolesi; Riccardo Manfredi; Vincenzo Valentini; Maria Antonietta Gambacorta
Journal:  Radiol Med       Date:  2021-11-01       Impact factor: 3.469

6.  MRI radiomics independent of clinical baseline characteristics and neoadjuvant treatment modalities predicts response to neoadjuvant therapy in rectal cancer.

Authors:  Maxiaowei Song; Shuai Li; Hongzhi Wang; Ke Hu; Fengwei Wang; Huajing Teng; Zhi Wang; Jin Liu; Angela Y Jia; Yong Cai; Yongheng Li; Xianggao Zhu; Jianhao Geng; Yangzi Zhang; XiangBo Wan; Weihu Wang
Journal:  Br J Cancer       Date:  2022-04-02       Impact factor: 9.075

7.  Radiomic Texture and Shape Descriptors of the Rectal Environment on Post-Chemoradiation T2-Weighted MRI are Associated with Pathologic Tumor Stage Regression in Rectal Cancers: A Retrospective, Multi-Institution Study.

Authors:  Charlems Alvarez-Jimenez; Jacob T Antunes; Nitya Talasila; Kaustav Bera; Justin T Brady; Jayakrishna Gollamudi; Eric Marderstein; Matthew F Kalady; Andrei Purysko; Joseph E Willis; Sharon Stein; Kenneth Friedman; Rajmohan Paspulati; Conor P Delaney; Eduardo Romero; Anant Madabhushi; Satish E Viswanath
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.639

8.  MRI radiomic signature predicts intracranial progression-free survival in patients with brain metastases of ALK-positive non-small cell lung cancer.

Authors:  Shijun Zhao; Donghui Hou; Xiaomin Zheng; Wei Song; Xiaoqing Liu; Sicong Wang; Lina Zhou; Xiuli Tao; Lv Lv; Qi Sun; Yujing Jin; Lieming Ding; Li Mao; Ning Wu
Journal:  Transl Lung Cancer Res       Date:  2021-01

9.  Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer.

Authors:  Zhuokai Zhuang; Zongchao Liu; Juan Li; Xiaolin Wang; Peiyi Xie; Fei Xiong; Jiancong Hu; Xiaochun Meng; Meijin Huang; Yanhong Deng; Ping Lan; Huichuan Yu; Yanxin Luo
Journal:  J Transl Med       Date:  2021-06-10       Impact factor: 5.531

10.  A Deep Learning Model to Predict the Response to Neoadjuvant Chemoradiotherapy by the Pretreatment Apparent Diffusion Coefficient Images of Locally Advanced Rectal Cancer.

Authors:  Hai-Tao Zhu; Xiao-Yan Zhang; Yan-Jie Shi; Xiao-Ting Li; Ying-Shi Sun
Journal:  Front Oncol       Date:  2020-10-29       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.